2026 WHO Trials: Health Crisis Preparedness Exposed
The 2026 WHO trials revealed critical gaps in global health crisis response. Learn why equitable medical distribution and decentralized data are key.
The 2026 WHO trials revealed critical gaps in global health crisis response. Learn why equitable medical distribution and decentralized data are key.
NCAA NIL deals are 90% skewed to football/men's basketball. This article explains why NIL is failing and what it means for college sports.
WHO's 2026 report shows uneven global health progress. Vaccine access rose 15%, but climate crises and drug-resistant pathogens are growing threats.
US IEEPA sanctions surged 1500+ since 2020. Learn why legal challenges fail 95% of the time & how these rules impact global business.
53% of AI projects fail. Learn why strong AI policy is key for success, scaling, and cutting compliance costs by 15%.
The WHO aims to close the vaccine access gap by 2028. See why equitable distribution is hard, with only 35% of pledged COVAX doses delivered.
WHO's 2026 clinical trial strategy misses genuine community engagement. Why it fails to recruit & retain, and what 1 key shift is needed.
Over 70% of IEEPA refund claims fail without legal counsel. Learn why, how to recover funds from OFAC, and what to watch for in 2026.
Why do vaccine access gaps persist in 2026? Learn how COVAX funding shortfalls and regulatory hurdles hinder equitable distribution.
IEEPA tariff refunds are going to corporations, not consumers. Find out why billions in Section 301 duties offer limited public benefit.